HomeFinancial MarketsFutures Slip as Big Pharma Earnings Roll In

Futures Slip as Big Pharma Earnings Roll In

Futures in New York edged lower on Tuesday following the latest influx of earnings from major pharmaceutical companies. Investors also remain focused on incoming economic data to better understand the trajectory of the U.S. economy.

Dow Jones e-minis declined by 51 points, or 0.14%, while S&P 500 e-minis fell by 7.25 points or 0.16%. Nasdsaq 100 e-minis fell by 32.5 points or 0.2%. This comes after the benchmark S&P 500 index hit a more than 15-month high on Monday. The index is now just 4.7% away from reaching its record intraday high on January 4, 2022.

Merck stock rose by 1.4% in premarket trading when the big pharma company raised its full-year profit forecast after beating analysts’ second-quarter estimates. Computing company Arista Networks jumped by 14.8% after beating its own Q2 earnings forecast, driven by demand for its cloud networking products.

Investors now await the ISM Manufacturing survey to assess U.S. factory activity in July. The Labor Department’s Job Openings and Labor Turnover Survey is also in the pipeline.

Goldman Sachs Lowers S&P 500 Target to 5,700 on Recession Risk and Tariff-Related Uncertainty

Banking giant Goldman Sachs is becoming increasingly pessimistic about the S&P 500’s chances to deliver a successful year. In a note sent to clients,...

Elon Musk Sells Social Media Platform X to His Own AI Startup xAI in a $33 Billion Deal

Tesla and SpaceX CEO Elon Musk announced on Friday that he is selling social media platform X, previously known as Twitter, to his own...

GameStop Announces Intention to Invest in Bitcoin

Struggling video game retailer GameStop will try to turn around its fortunes by adopting a strategy of corporate investments in cryptocurrency. The company announced...